Drug Profile
Mycobacterium avium vaccine - Antigenics
Latest Information Update: 19 Aug 1999
Price :
$50
*
At a glance
- Originator Antigenics
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycobacterium avium complex infections
Most Recent Events
- 19 Aug 1999 Discontinued-Preclinical for Mycobacterium avium complex infections in USA (Unknown route)
- 20 Jul 1998 No-Development-Reported for Mycobacterium avium complex infections in USA (Unknown route)
- 03 Aug 1995 New profile